Emerging research suggest Retatrutide , a dual agonist targeting both incretin and glucose-dependent insulinotropic polypeptide , may offer a significant development for weight management . Preliminary https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide